Alfuzosin HCl
Alfuzosin HCl is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Uroxatral. Available dosage form: tablet, extended release.
Drug Details
- Generic Name
- Alfuzosin HCl
- Brand Names
- Uroxatral
- Application Number
- NDA021287
- Sponsor
- Advanz Pharma (US) Corp.
- NDC Codes
- 1
- Dosage Forms
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- ALFUZOSIN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE UROXATRAL is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. UROXATRAL is an alpha adrenergic antagonist, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. ( 1 ) Important Limitations of Use: UROXATRAL is not indicated for treatment of hypertension. ( 1.1 ) UROXATRAL is not indicated for use in the pediatric population. ( 1.1 , 8.4 , 12.3 ) 1.1 Important Limitations of Use UROXATRAL is not indicated for the treatment of hypertension. UROXATRAL is not indicated for use in the pediatric population.